Michael Gal
Overview
Explore the profile of Michael Gal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagawkar Perlov S, Deri N, Eldar-Geva T, Gal M, Reichman O, Or Y, et al.
J Assist Reprod Genet
. 2025 Jan;
42(2):689.
PMID: 39786531
No abstract available.
2.
Nagawkar Perlov S, Deri N, Eldar-Geva T, Gal M, Reichman O, Or Y, et al.
J Assist Reprod Genet
. 2024 Sep;
41(10):2681-2690.
PMID: 39331312
Purpose: To compare obstetrical and neonatal outcomes of embryo transfer cycles using fresh vs. frozen-thawed testicular sperm derived from microTESE in non-obstructive azoospermia (NOA) patients. Design: The retrospective cohort study...
3.
Trop-Steinberg S, Gal M, Azar Y, Kilav-Levin R, Heifetz E
Heliyon
. 2024 Apr;
10(8):e29324.
PMID: 38628754
Objective: This study aimed to assess the effect of increased omega-3 consumption on fertilization rates and the probability of women getting pregnant. This study is needed because different perspectives exist...
4.
Trop-Steinberg S, Heifetz E, Azar Y, Kafka I, Weintraub A, Gal M
Isr Med Assoc J
. 2023 Feb;
25(2):131-136.
PMID: 36841983
Background: Omega-3 fatty acids promote fertility in males and females and constitute an important factor in the normal development of the fetus. Objectives: We investigated the effect of omega-3 supplements...
5.
Tsafrir A, Ben-Ami I, Eldar-Geva T, Gal M, Dekel N, Levi H, et al.
J Assist Reprod Genet
. 2022 Oct;
39(11):2625-2633.
PMID: 36264444
Purpose: To report outcome of planned oocyte cryopreservation (POC) in the first 8 years of this treatment in our center. Methods: A retrospective study in a university-affiliated medical center. Results:...
6.
Miron-Shatz T, Holzer H, Revel A, Weissman A, Tarashandegan D, Hurwitz A, et al.
Reprod Biomed Online
. 2020 Nov;
42(2):463-470.
PMID: 33250411
Research Question: Why are women who face poor prognoses for success in assisted reproductive technology (ART) treatment choosing to pursue procedures using their own eggs, despite receiving information that their...
7.
Tsafrir A, Lerner-Geva L, Zaslavsky-Paltiel I, Laufer N, Simon A, Einav S, et al.
Reprod Biomed Online
. 2020 Feb;
40(3):369-373.
PMID: 32008887
Research Question: Current knowledge of cancer risk among women who undergo IVF is based mainly on studies of women treated in their thirties, frequently with short follow-up periods. Therefore, information...
8.
Gal M, Fertouk M, Volodarsky-Perel A, Reichman O, Holzer H, Eldar-Geva T
Int J Gynaecol Obstet
. 2017 Jan;
136(3):352-353.
PMID: 28099687
No abstract available.
9.
Volodarsky-Perel A, Eldar-Geva T, Holzer H, Schonberger O, Reichman O, Gal M
Reprod Biomed Online
. 2017 Jan;
34(3):267-273.
PMID: 28041829
The optimal time to perform cryopreserved embryo transfer (CET) after a failed oocyte retrieval-embryo transfer (OR-ET) cycle is unknown. Similar clinical pregnancy rates were recently reported in immediate and delayed...
10.
Goldberg D, Tsafrir A, Srebnik N, Gal M, Margalioth E, Mor P, et al.
Isr Med Assoc J
. 2016 Jul;
18(6):313-7.
PMID: 27468521
Background: Fertility treatments are responsible for the rise in high order pregnancies in recent decades and their associated complications. Reducing the number of embryos returned to the uterus will reduce...